Foresite Capital Management I’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Foresite Capital Management I’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$2.59M	Hold	122,929	–	–	27.66%	3
2015 Q2	$6.08M	Hold	122,929	–	–	40.17%	1
2015 Q1	$9.63M	Sell	122,929 -571	-0.5%	-$35.4K	44.28%	1
2014 Q4	$7.48M	Hold	123,500	–	–	11.02%	4
2014 Q3	$5.26M	Sell	123,500 -1,500	-1%	-$80.5K	5.04%	5
2014 Q2	$7.72M	Hold	125,000	–	–	6.48%	6
2014 Q1	$8.13M	Buy	+125,000	New	+$8.45M	5.71%	6

Other funds holding OREX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Foresite Capital Management I's OREX Position: Q3 2015 in Review

Foresite Capital Management I held its Orexigen Therapeutics, Inc. (OREX) position steady in Q3 2015 at 122,929 shares worth $2.59M. The position accounts for 27.66% of the portfolio, ranked #3.

Foresite Capital Management I first reported a position in OREX in Q1 2014 and has held it in 7 quarters since. The position peaked at $9.63M in Q1 2015. 132 funds tracked by Wall St. Rank hold OREX as of Q3 2015.

Foresite Capital Management I held 122,929 shares of Orexigen Therapeutics, Inc. worth $2.59M as of Q3 2015.
Foresite Capital Management I left its Orexigen Therapeutics, Inc. share count unchanged in Q3 2015.
Orexigen Therapeutics, Inc. made up 27.66% of Foresite Capital Management I's portfolio in Q3 2015, its #3 holding.
Foresite Capital Management I first reported a position in Orexigen Therapeutics, Inc. in Q1 2014 and has held it in 7 quarters since.
Foresite Capital Management I's Orexigen Therapeutics, Inc. position peaked at $9.63M in Q1 2015.
132 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2015.

Based on Foresite Capital Management I's 13F filing for Q3 2015, filed 13 Nov 2015.